Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
The Department of Chemistry invites applicants for a PhD fellowship in computational homogenous catalyst discovery. Start date is 1.9.2025 or as soon as possible thereafter. The project The project
-
Faculty of Health and Medical Sciences, University of Copenhagen We are offering a PhD fellowship in the Rengtved Lundegaard group in Cardiac Functional Genomics commencing on 1 November 2025 or as
-
We are seeking an outstanding candidate for a PhD fellowship in the field of computational fluid and solid mechanics. The fellowship will start on September 1st, 2025, or as soon as possible after
-
“Quantum Quenches from Quantum Fields” at the Niels Bohr International Academy (NBIA) at the Niels Bohr Institute (NBI) requests expressions of interest for a PhD position in theoretical high energy physics
-
written and spoken English. Fluent in a computer coding language (python or Matlab or C++ or etc). The Scientific environment We offer creative and stimulating working conditions in a dynamic and
-
collaboration, as part of the employment process at the University of Copenhagen. Notice: In the following description of the PhD programmes, some references are made to SCIENCE websites The PhD programme
-
, Section for Environmental Chemistry and Physics, jch@plen.ku.dk , phone: +4535332456. The PhD programme Depending on your level of education, you can undertake the PhD programme as either: Option A: A
-
PhD programme, you must have completed a degree programme, equivalent to a Danish master’s degree (180 ECTS/3 FTE BSc + 120 ECTS/2 FTE MSc) related to the subject area of the project, e.g. in Human
-
of Health and Medical Sciences. The PhD study must be completed in accordance with The Ministerial Order on the PhD programme (2013) and the Faculty’s rules on achieving the degree. The PhD student is
-
be integrated in the Kloverpris lab as part of NIVI-R. Project description The PhD project will focus on tracking the immune and epithelial changes in the respiratory tract from a human clinical trial